A detailed history of Belvedere Trading LLC transactions in Grifols Sa stock. As of the latest transaction made, Belvedere Trading LLC holds 7,298 shares of GRFS stock, worth $47,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,298
Holding current value
$47,582
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$5.47 - $11.38 $39,920 - $83,051
7,298 New
7,298 $48,000
Q2 2023

Aug 08, 2023

SELL
$7.14 - $9.29 $93,648 - $121,847
-13,116 Reduced 80.23%
3,232 $29,000
Q1 2023

May 15, 2023

BUY
$6.65 - $10.69 $2,254 - $3,623
339 Added 2.12%
16,348 $120,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $95,413 - $136,556
16,009 New
16,009 $136,000
Q4 2020

Feb 10, 2021

SELL
$16.86 - $19.67 $240,491 - $280,572
-14,264 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$15.4 - $20.16 $219,665 - $287,562
14,264 New
14,264 $247,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.43B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.